AI is already accelerating drug discovery and health delivery. It has great potential to accelerate research, workflow and processes, and even reengineer entire healthcare systems. But what challenges must be addressed first? Shahram Ebadollahi and Ann Aerts share the ideas they discussed at the Intelligent Health summit in Basel this week.

Novartis’ Don Ganem tapped as a scientific advisor for the Chan Zuckerberg Biohub

Great progress has been made against malaria, but signs of resistance are becoming a rising concern

Accelerating Research to Get Answers Faster

Oncology Regulatory Affairs Leader Hannah Mosca describes her lifelong interest in science and math, and what it’s like to work at Novartis

A Novartis experimental drug in clinical trial aims to block liver cancer growth

The word “biopsy” typically conjures images of large needles. Lab technicians—and scientists working to discover new medicines—need enough tissue from a patient to prepare and evaluate a sample.

Using new technologies, researchers have developed a deeper understanding of how cells function, changing conceptions of disease.